|
|
 |
|
Viewing report
|
|
|
|
Genzyme Corporation Product Pipeline Analysis
Global Markets Direct, Aug 2008, Pages: 66
Genzyme Corporation Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Genzyme Corporation’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.
Customers who bought this item also bought
Companion Diagnostics - Global Strategic Business Report
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials
Endpoints-Clinical Trials in Orphan Diseases - Highest Number of Terminated Trials Focused on Mulitiple Myeloma
Point of Care Diagnostic Testing World Markets
Clinical Trial Management Systems (CTMS) Market: Global Trends, Opportunities, Challenge and Forecasts (2011 – 2016)
Lou Gehrigs Disease - Global Strategic Business Report
Transcatheter Heart Valve Market to 2017 - Improvements in Design and Technique and a Favorable Reimbursement Scenario to Contribute to Higher Procedure Volumes
Neurostimulation Devices Pipeline Product and Technology Analysis Report
Clinical Laboratory Testing Volume 2: Business Strategies
|
|
|
|
